Clinical Report: UCI Health earns NAEC Level 4 Epilepsy Center certification
Overview
UCI Health has achieved NAEC Level 4 Epilepsy Center certification for the 2026–2028 cycle, the highest designation for comprehensive epilepsy care.
Background
The designation of Level 4 Epilepsy Center by the National Association of Epilepsy Centers (NAEC) signifies the highest standard of care in the management of epilepsy. This certification ensures that patients have access to comprehensive, multidisciplinary services, including advanced diagnostics and therapeutic options for complex epilepsy.
Data Highlights
No numerical data available in the source material.
Key Findings
UCI Health has been awarded NAEC Level 4 Epilepsy Center certification for 2026–2028.
This certification reflects a commitment to high standards of care for complex epilepsy.
UCI Health's multidisciplinary team contributed to achieving this designation.
Level 4 centers must provide advanced diagnostics and therapeutic options, including epilepsy surgery.
NAEC guidelines emphasize the importance of specialized care for drug-resistant epilepsy.
Clinical Implications
The NAEC Level 4 certification allows UCI Health to provide comprehensive care for patients with complex epilepsy, including access to advanced treatment options.
Conclusion
UCI Health's certification as a Level 4 Epilepsy Center reflects its achievement in delivering high-quality care for patients with complex epilepsy.
Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward
